JOSEPH CADAYONA: Open Payments
NPI 1750803490 · HINSDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$764 in 33 payments from 11 companies in 2025. Trend: 2023 $412 · 2024 $1,233 · 2025 $764
Food & beverage: $764
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $181 |
| Biogen, Inc. | 6 | $145 |
| Teva Pharmaceuticals USA, Inc. | 4 | $107 |
| PFIZER INC. | 4 | $96 |
| Genentech USA, Inc. | 4 | $95 |
| Janssen Biotech, Inc. | 1 | $31 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| UCB, Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| ACADIA Pharmaceuticals Inc | 1 | $19 |
Products named: TYSABRI, AUSTEDO XR, Ocrevus Zunovo, QULIPTA, UBRELVY, NURTEC ODT, ZAVZPRET, Symbravo.
Industry payments across IL — which companies pay providers there.
